Terms: = Uterine cancer AND SFRP4, Q6FHJ7, 6424, ENSG00000106483, frpHE, MGC26498, FRPHE, FRP-4 AND Treatment
4 results:
1. Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010.
Nagase S; Ohta T; Takahashi F; Enomoto T;
J Obstet Gynaecol Res; 2019 Feb; 45(2):289-298. PubMed ID: 30426591
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Key Candidate Genes and Pathways in Endometrial cancer by Integrated Bioinformatical Analysis.
Liu L; Chen F; Xiu A; Du B; Ai H; Xie W
Asian Pac J Cancer Prev; 2018 Apr; 19(4):969-975. PubMed ID: 29693365
[TBL] [Abstract] [Full Text] [Related]
3. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells.
Zhang Y; Chen FQ; Sun YH; Zhou SY; Li TY; Chen R
J Exp Clin Cancer Res; 2011 Oct; 30(1):98. PubMed ID: 21999220
[TBL] [Abstract] [Full Text] [Related]
4. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells.
Carmon KS; Loose DS
Mol Cancer Res; 2008 Jun; 6(6):1017-28. PubMed ID: 18567805
[TBL] [Abstract] [Full Text] [Related]
